222

EUTILEX CO., LTD.

No trades
See on Supercharts
Market capitalization
‪84.82 B‬KRW
−660KRW
‪−27.72 B‬KRW
‪131.65 M‬KRW
‪28.51 M‬
Beta (1Y)
0.07
Employees (FY)
89
Change (1Y)
−14 −13.59%
Revenue / Employee (1Y)
‪1.14 K‬KRW
Net income / Employee (1Y)
‪−239.19 K‬KRW

About EUTILEX CO., LTD.


Headquarters
Seoul
Founded
2015
ISIN
KR7263050007
FIGI
BBG00MKJH1K4
Eutilex Co., Ltd. develops anti-tumor T cell therapy and antibody therapeutics based on proprietary immunotherapy technology. It offers T Cell Therapy, Antibody, CAR-T Cell Therapy. The company was founded by Kwon Byoung S on February 27, 2015 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 263050 is 2,430 KRW — it has increased by 3.47% in the past 24 hours. Watch EUTILEX CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange EUTILEX CO., LTD. stocks are traded under the ticker 263050.
263050 stock has risen by 6.71% compared to the previous week, the month change is a −0.21% fall, over the last year EUTILEX CO., LTD. has showed a −6.36% decrease.
263050 reached its all-time high on Mar 18, 2019 with the price of 41,385 KRW, and its all-time low was 1,765 KRW and was reached on Jun 27, 2024. View more price dynamics on 263050 chart.
See other stocks reaching their highest and lowest prices.
263050 stock is 9.80% volatile and has beta coefficient of 0.07. Track EUTILEX CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is EUTILEX CO., LTD. there?
Today EUTILEX CO., LTD. has the market capitalization of ‪84.81 B‬, it has increased by 3.60% over the last week.
Yes, you can track EUTILEX CO., LTD. financials in yearly and quarterly reports right on TradingView.
263050 net income for the last quarter is ‪−5.20 B‬ KRW, while the quarter before that showed ‪−6.17 B‬ KRW of net income which accounts for 15.84% change. Track more EUTILEX CO., LTD. financial stats to get the full picture.
No, 263050 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 89.00 employees. See our rating of the largest employees — is EUTILEX CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUTILEX CO., LTD. EBITDA is ‪−21.54 B‬ KRW, and current EBITDA margin is ‪−19.72 K‬%. See more stats in EUTILEX CO., LTD. financial statements.
Like other stocks, 263050 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUTILEX CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUTILEX CO., LTD. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUTILEX CO., LTD. stock shows the sell signal. See more of EUTILEX CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.